Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
about
Polyanhydride Nanoparticle Delivery Platform Dramatically Enhances Killing of Filarial WormsHemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunityPolyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody ResponsesSafety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticlesRespiratory nanoparticle-based vaccines and challenges associated with animal models and translationCombinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.Anthrax vaccines: present status and future prospects.Recent progress toward development of vaccines against conception.Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives.Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.
P2860
Q28550462-CDB9AE39-7EB3-4B32-A0CA-C1B182477174Q30370494-649A6469-A537-4B57-B8C9-52F2559CD828Q33710195-73AB4C2F-DD67-46C6-9EAD-DADDAF8DB00FQ34871862-AE9997A1-6EC2-4109-A423-6FF89304FAE2Q36122915-DEFBF3DE-0762-448B-9490-2DCD4E6380CDQ36582010-C5A5FC5D-5DC8-45FF-B904-ADBA2C76D822Q36598433-083806E0-089B-48FB-AF59-9DFA8CAC0172Q36957938-F924783E-D742-417F-91F0-6A49EB43B31DQ37184111-774BB40E-F11B-4D3E-9F78-CD9BF7FF1526Q38132268-7A2E8DE0-869E-411A-A027-9BEE2A813858Q38168910-AB3525D4-BE67-4E2A-B72D-DC16F32F7950Q38215454-9208C026-92BD-4C86-ADC1-0137E06037B2Q38757220-1186F122-CAD3-42E5-997E-0E341E7D3EB8Q41382022-60BB20C9-1910-49CD-8AF7-0A75B43BBA6EQ41879397-F43619C4-945E-4794-BAEB-A44E38CD9BE7Q42114702-36F9D82C-9D16-49DC-BEA0-18A0F5F9840DQ42242342-74F2B92E-C695-4C22-A480-4D9D4E96978DQ50317606-CAD13872-8FA7-4027-9E86-DF2EEE1C54D3Q51732398-2CE603EA-31DD-4C44-A0EA-4B3846FE16AC
P2860
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
@ast
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
@en
type
label
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
@ast
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
@en
prefLabel
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
@ast
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
@en
P2093
P2860
P356
P1476
Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen
@en
P2093
B Narasimhan
L K Petersen
M J Wannemuehler
P2860
P304
P356
10.1021/MP2004059
P407
P577
2012-03-20T00:00:00Z